BMA vs IBOC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 24, 2026
BMA
IBOC
Investment Advisor Scores
IBOC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BMA | IBOC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 3.0979 | 9.8135 | BMA |
| PEG Ratio | 0.4681 | 0.9812 | BMA |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -99.6% | 0.0% | IBOC |
| Earnings Growth | -27.4% | -4.3% | IBOC |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 51.5/100 | 58.8/100 | IBOC |
| Profit Margin | 7.6% | 49.3% | IBOC |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | BUY | IBOC |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BMA
NeutralMixed signals - no dominant trend phase, RSI 29
IBOC
NeutralMixed signals - no dominant trend phase, RSI 33
Fundamentals Snapshot
| Metric | BMA | IBOC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 10.6 |
| Trailing P/E | 19.3 | 10.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | -1.0% | 0.0% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.7% | 0.6% |
| EPS | 3.77 | 6.65 |
| Dividend Yield | 0.07% | 0.02% |